Gregor Reid

TL;DR: An expert panel was convened in October 2013 by the International Scientific Association for Probiotics and Prebiotics (ISAPP) to discuss the field of probiotics and the appropriate use and scope of the term probiotic.

TL;DR: The goal of this Consensus Statement is to engender appropriate use of the term 'prebiotic' by relevant stakeholders so that consistency and clarity can be achieved in research reports, product marketing and regulatory oversight of the category.

TL;DR: This Consensus Statement outlines the definition and scope of the term ‘synbiotics’ as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in May 2019 and explores the levels of evidence, safety, effects upon targets and implications for stakeholders of the synbiotic concept.

TL;DR: There is mounting evidence that selected probiotic strains can provide health benefits to their human hosts, and accepted standards and guidelines proposed by the Food and Agriculture Organization of the United Nations and the World Health Organization represent a key step in ensuring that reliable products with suitable, informative health claims become available.

TL;DR: Gut-derived effects in humans is described, a review of current understanding of probiotics and prebiotics as a means to manage the microbiota to improve host health, including mechanisms of actions and potential for clinical use.